The effect of efavirenz versus nevirapine-containing regimens in the HIV-CAUSAL Collaboration: reply to Llibre and Podzamczer and additional results

AIDS. 2013 Aug 24;27(13):2169-70. doi: 10.1097/01.aids.0000432446.15061.27.

Authors

Lauren E Cain¹, Miguel A Hernán; HIV-CAUSAL Collaboration

Affiliation

¹ aDepartment of Epidemiology, Harvard School of Public Health, Boston, MA, USA bDepartment of Epidemiology, Harvard School of Public Health and Harvard-MIT Division of Health Sciences and Technology, Boston, MA, USA.

PMID: 24384594
DOI: 10.1097/01.aids.0000432446.15061.27

No abstract available

Publication types

Comment

MeSH terms

Anti-HIV Agents / pharmacology*
Benzoxazines / pharmacology*
HIV Infections / drug therapy*
Hepatitis C / drug therapy*
Humans
Nevirapine / pharmacology*
Reverse Transcriptase Inhibitors / pharmacology*

Substances

Anti-HIV Agents
Benzoxazines
Reverse Transcriptase Inhibitors
Nevirapine